Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • sharpo
    Junior Member
    • Sep 2017
    • 6

    Why illumina index is read separately?

    Hi.

    illumina has total 3 reads (see attached image):
    1. Read1 > followed by removal/wash-off of Read1 product
    2. Index read (read separately after binding of Index Primer downstream)
    3. Read2

    Any idea why Index can't be read continuously down as part of Read1? Has this something to do with the sequencing length limit of Read1 or some other technical constraint?

    Thank you!
    Attached Files
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    In theory when the insert is shorter than the read length you do read into the adapter at other end and then will sequence the index. Problem is not all inserts in your library are the same length and may not even be shorter than read length. So you would not be guaranteed to reach and read the index each time. One would want the indexes to be read consistently so a separate primer is used to ensure that. Both Index 1 and 2 are read as separate reads.

    Comment

    • sharpo
      Junior Member
      • Sep 2017
      • 6

      #3
      Thanks GenoMax! That makes sense.

      Comment

      • Brian Bushnell
        Super Moderator
        • Jan 2014
        • 2709

        #4
        Also, it's worth noting that Illumina base quality is reduced with each successive cycle due to phasing drift. This phasing drift is reset when a new read begins starting at a primer location. Therefore, reading the indexes independently, starting with their own primers, allows the index bases to be read without adding error to (or reducing the length of) the genomic bases.

        Comment

        • sharpo
          Junior Member
          • Sep 2017
          • 6

          #5
          Originally posted by Brian Bushnell View Post
          Also, it's worth noting that Illumina base quality is reduced with each successive cycle due to phasing drift. This phasing drift is reset when a new read begins starting at a primer location. Therefore, reading the indexes independently, starting with their own primers, allows the index bases to be read without adding error to (or reducing the length of) the genomic bases.
          Thanks Brian! That is very useful info. Never thought of the quality aspect; but true, this is very important.

          Comment

          • luc
            Senior Member
            • Dec 2010
            • 469

            #6
            The first indexed adapter designs were actually "in-line" indices.
            Today they are only rarely used because of the already mentioned reasons and:

            - the first five bases can be critical for the cluster registration and the "calibration" of the basecaller ; these sequences should be of high diversity and not low diversity sequences like barcodes. There were frequently problems with the "balancing" of these barcodes
            - in-line barcode adapters are more expensive to generate since you need two complementary oligos for each index; not so for TruSeq and Nextera style adapter oligos. Thus, the latter allow also dual-indexing.

            Comment

            • sharpo
              Junior Member
              • Sep 2017
              • 6

              #7
              Originally posted by luc View Post
              The first indexed adapter designs were actually "in-line" indices.
              Today they are only rarely used because of the already mentioned reasons and:

              - the first five bases can be critical for the cluster registration and the "calibration" of the basecaller ; these sequences should be of high diversity and not low diversity sequences like barcodes. There were frequently problems with the "balancing" of these barcodes
              - in-line barcode adapters are more expensive to generate since you need two complementary oligos for each index; not so for TruSeq and Nextera style adapter oligos. Thus, the latter allow also dual-indexing.
              Thanks luc! That is very helpful information.

              Comment

              Latest Articles

              Collapse

              • SEQadmin2
                Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                by SEQadmin2


                Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                The systematic characterization of the human proteome has
                ...
                07-20-2026, 11:48 AM
              • SEQadmin2
                Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                by SEQadmin2



                Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                ...
                07-09-2026, 11:10 AM
              • SEQadmin2
                Cancer Drug Resistance: The Lingering Barrier to Rising Survival
                by SEQadmin2



                Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

                There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
                07-08-2026, 05:17 AM

              ad_right_rmr

              Collapse

              News

              Collapse

              Topics Statistics Last Post
              Started by SEQadmin2, Yesterday, 11:41 AM
              0 responses
              9 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-20-2026, 11:10 AM
              0 responses
              23 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-13-2026, 10:26 AM
              0 responses
              36 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-09-2026, 10:04 AM
              0 responses
              45 views
              0 reactions
              Last Post SEQadmin2  
              Working...